Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zilli

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 15, 2020
Postoperative Radiation Therapy in Patients with Extracranial Chondrosarcoma: A Joint Study of the French Sarcoma Group and Rare Cancer NetworkMario Terlizzi, Cécile Le Pechoux, Sébastien Salas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohortFilippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2022
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensusThomas Zilli, Vérane Achard, Alan Dal Pra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E<sup>2</sup>-RADIatE OligoCare studySebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
European Urology Oncology|April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective StudyNicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
European Urology|May 22, 2023
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary FacultyAristotelis Bamias, Arnulf Stenzl, Stephanie L Brown, et al.
European Urology Oncology|January 21, 2026
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized TrialThomas Zilli, Shankar Siva, Sigmund Brabrand, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2020
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectivesVérane Achard, Daniel M Aebersold, Abdelkarim S Allal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2022
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trialVérane Achard, Maud Jaccard, Frederik Vanhoutte, et al.
The Lancet. Oncology|May 8, 2025
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|April 15, 2020
Postoperative Radiation Therapy in Patients with Extracranial Chondrosarcoma: A Joint Study of the French Sarcoma Group and Rare Cancer NetworkMario Terlizzi, Cécile Le Pechoux, Sébastien Salas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohortFilippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 13, 2022
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensusThomas Zilli, Vérane Achard, Alan Dal Pra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E<sup>2</sup>-RADIatE OligoCare studySebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
European Urology Oncology|April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective StudyNicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
European Urology|May 22, 2023
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary FacultyAristotelis Bamias, Arnulf Stenzl, Stephanie L Brown, et al.
European Urology Oncology|January 21, 2026
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized TrialThomas Zilli, Shankar Siva, Sigmund Brabrand, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2020
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectivesVérane Achard, Daniel M Aebersold, Abdelkarim S Allal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2022
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trialVérane Achard, Maud Jaccard, Frederik Vanhoutte, et al.
The Lancet. Oncology|May 8, 2025
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
Pageof 24